Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 552 results for "maa exchange"

Union minister Jual Oram faults Odisha CM for irresponsible be...

Classifieds Add E-Commerce Delivery "Happy Birthday to you, Maa with Lots of Love Lipi" Best wishes through Orissa India E-Commerce Service! BAck to news list Union minister Jual Oram faults Odisha Chief ... Orissa India, 1 day ago

MSM - Cancellation Notice

REPORT OF THE BOARD OF THE IRISH STOCK EXCHANGE CANCELLATION NOTICE Irish Stock Exchange 28 Anglesea Street Dublin 2 20th November 2014 Listing and trading of the under mentioned security has been cancelled with effect from 20th ...
 MoneyAM2 days ago

ZS Pharma Announces Publication of Results From Phase 3 Study of ZS-9 in Patients With Hyperkalemia in the New England Journal of Medicine

COPPELL, Texas, Nov. 21, 2014 (GLOBE NEWSWIRE) -- ZS Pharma ( Nasdaq:ZSPH ), a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the publication of previously unreleased ...
 Wall Street Business Network1 day ago ZS Pharma Hosts and Webcasts Investor Event  Scottrade3 days ago ZS PHARMA : Announces Publication of Results From Phase 3 Study of ZS-9 in Patients With Hyperkalemia in the New England Journal of Medicine  4 Traders1 day ago ZS Pharma Presents Positive Results From HARMONIZE (ZS004), a Second Phase 3 Clinical Trial of ZS-9 in Patients With Hyperkalemia, at the American Heart Association Scientific Meeting and Announces Si  Wall Street Business Network6 days ago
[x]  
Datamation

Google Sends Android to Work with Divide BYOD App

Google is making moves to heighten Android's profile in the enterprise. The tech giant quietly released a business-minded version of the Divide app on the Google Play store. The app, which delivers a secure containerized workspace, is available ...
 Datamation1 day ago

CHMP Grants Positive Opinions of AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir) + EXVIERA (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe

NORTH CHICAGO, Ill. , Nov. 21, 2014 /PRNewswire/ --The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted positive opinions for AbbVie's ( NYSE: ABBV ) investigational, all-oral, ...
 Reliance Trust2 days ago Enanta Announces CHMP Grants Positive Opinions of AbbVie's VIEKIRAX? (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA? (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe  Pharmacy Choice1 day ago AbbVie : CHMP Grants Positive Opinions of AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir) + EXVIERA (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe  4 Traders2 days ago Enanta Pharmaceuticals : Announces CHMP Grants Positive Opinions of AbbVie's VIEKIRAX (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe  4 Traders2 days ago
[x]  
Stuff.co.nz

Chinese President talks trade with Key

Friday 21st November 2014 Prime Minister John Key's playing tour guide to the Chinese president has resulted in the signing of ten new agreements. President Xi Jingping received a red carpet reception, a 21 gun salute, and a lucky number eight ...
 The Wireless2 days ago Chinese President Xi Jinping given ABs jersey  Stuff.co.nz3 days ago
Gulf News

Govind Nihalani slams filmmaker courses

Students are banking more on quick results and less on links with history, says the director National Award-winning director and cinematographer Govind Nihalani has lashed out at shortcut courses in filmmaking for their failure to infuse Indian ...
 Gulf News3 days ago Filmmakers cannot be made through 'shortcut' …  Yahoo! India4 days ago Govind Nihalani: Filmmakers cannot be made through 'shortcut' courses  Times of India3 days ago Filmmakers cannot be made through shortcut courses Govind Nihalani  Bombay News.Net4 days ago
[x]  

Interim Data from Rociletinib (CO-1686) Phase 1/2 Study Shows Compelling and Durable Clinical Activity and Progression-free Survival (PFS) in Patients with EGFR-Mutant Non-small Cell Lung Cancer (NSCLC)

67% objective response rate (ORR) observed in evaluable heavily-pretreated T790M+ patients treated with 625mg or 500mg BID (clinical dose group) Median PFS of 10.4 months in clinical dose group; data continue to mature Well-tolerated majority of ...
 CNBC4 days ago Clovis Oncology Release: Interim Data From Rociletinib (CO-1686) Phase 1/2 Study Shows Compelling And Durable Clinical Activity And Progression-Free Survival (PFS) In Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)  BioSpace3 days ago
[x]  

I'm not your sister, mister!

Behen, right after ma, is one of the most prized possessions a person has. When you tack on a bad word or two - the curse has maximum impact. Women turn into census surveyors while being harassed and molested on the streets by asking "Ghar pe ...
 DNA India3 days ago

Oral OTEZLA® (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis

ACR 20 response rates sustained with continued OTEZLA treatment through 104 weeks - 65.3 percent and 61.4 percent in PALACE 1 and 4, respectively Eighty four percent of patients who completed one year of treatment with OTEZLA continued on OTEZLA ...
 CNBC5 days ago Oral OTEZLA (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis  Pharmacy Choice4 days ago Oral OTEZLA(r) (Apremilast) Showed Sustained Clinical Response over...  Finwin5 days ago Celgene : Oral OTEZLA® (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis  4 Traders5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less